Key Points Interested in iShares Biotechnology ETF? Here are five stocks we like better. The iShares Nasdaq Biotechnology ETF ...

IBB, one of the largest exchange-traded funds focused on biotechnology, manages approximately $8.28 billion in assets and ...

Against that backdrop, Seeking Alpha's Quant Ratings highlight a number of biotechnology companies that currently rank among ...

Ernst & Young's 2026 biotech report shows 13% revenue growth to $232B, but US policy shifts, patent cliffs and uneven ...

Biopharma dealmaking is driven by pressure to top up drug pipelines ahead of major patent expirations later this decade.

Prosper Junior Bakiny has positions in Vertex Pharmaceuticals. The Motley Fool has positions in and recommends CRISPR ...

Nasdaq has long been the home for biotech companies, and this past January, National Biotechnology Month proved no different. The sector was active with five healthcare companies raising $800 million ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

The bulk of coverage towards the top gaining stock sectors over the past year has focused understandably on technology, which has made huge strides, with semiconductors exceeding +60%. However, the ...

While SpaceX dazzles with a $2 trillion valuation, Massachusetts’ biotech sector is quietly stacking wins that save lives and ...

Korea Herald correspondent SAN DIEGO — Korea’s biotechnology sector faces a shrinking window of opportunity as China’s surge ...

Taiwan is showcasing the strength of its biotechnology ecosystem at BIO International Convention 2026 in San Diego from June ...